Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation
The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®.
Proxima is an integrated platform, resulting from five years of collaboration with major players in the Life Science Industries (big pharmas, medium and large CMOs). The software suite maximizes the potential of user expertise, predictive simulation, and analysis of experimental data. It enables the development, evaluation and optimization of processes in a collaborative, rational and efficient manner.
With the launch of Proxima in mid-2021, Ypso-Facto aims to become a leading partner in the digital transformation of the chemical and biotech industries.
This investment will allow Ypso-Facto to strengthen its team and continue its growth.
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.